Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hemangiosarcoma × carotuximab × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Paclitaxel 3 pembrolizumab 2 Standard of Care 2 Doxorubicin 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 talazoparib 1 selinexor 1 sarilumab 1 regorafenib 1 pexidartinib 1 pertuzumab 1 peginterferon alfa-2a 1 pazopanib 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 eribulin 1 durvalumab 1 dostarlimab 1 cemiplimab 1 abemaciclib 1 Trastuzumab 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡